Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jun. 30, 2018 |
Jun. 30, 2017 |
|
| Income Statement [Abstract] | ||||
| Net sales | $ 1,599,642 | $ 1,567,191 | $ 3,267,580 | $ 2,938,881 |
| Cost of sales | 1,243,569 | 1,272,551 | 2,532,411 | 2,344,325 |
| Gross profit | 356,073 | 296,640 | 735,169 | 594,556 |
| Operating expenses: | ||||
| Selling and general administrative | 160,668 | 146,162 | 315,660 | 298,616 |
| Salaries, wages and payroll taxes | 185,231 | 181,870 | 365,951 | 334,594 |
| Stock based compensation | 600,000 | 600,000 | ||
| Professional fees | 51,776 | 119,809 | 160,968 | 268,655 |
| Depreciation and amortization | 71,440 | 74,086 | 146,713 | 150,158 |
| Total operating expenses | 469,115 | 1,121,927 | 989,292 | 1,652,023 |
| Loss before other expenses and income taxes | (113,042) | (825,287) | (254,123) | (1,057,467) |
| Other (income) expense | ||||
| Change in fair value of derivative instruments, net | (123) | 1,237 | ||
| Interest expense | 34 | 218 | 110 | 436 |
| Other expense - Subscription Holders Preferred | 2,308,981 | 2,308,981 | ||
| Foreign currency exchange rate variance | 10,544 | (3,847) | 14,845 | (5,374) |
| Total other expense | 10,578 | 2,305,229 | 14,955 | 2,302,806 |
| Net loss | (123,620) | (3,130,516) | (269,078) | (3,360,273) |
| Comprehensive Income: | ||||
| Net loss | (123,620) | (3,130,516) | (269,078) | (3,360,273) |
| Foreign currency translation adjustments | (12,127) | 9,050 | (7,127) | (14,642) |
| Comprehensive loss | $ (135,747) | $ (3,121,466) | $ (276,205) | $ (3,345,631) |
| NET INCOME LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS | ||||
| Weighted number of common shares outstanding - basic | 936,519 | 447,017 | 733,865 | 290,973 |
| Weighted number of common shares outstanding - diluted | 936,519 | 447,017 | 733,865 | 290,973 |
| Basic net (loss) per share | $ (0.14) | $ (6.98) | $ (0.36) | $ (11.50) |
| Diluted net (loss) per share | $ (0.14) | $ (6.98) | $ (0.36) | $ (11.50) |
| X | ||||||||||
- Definition Represents gains or losses resulting from transactions conducted in foreign currencies. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of interest expense classified as other. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
- Definition Amount of tax expense (benefit) allocated to other comprehensive income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|